Anonymous
Guest
Anonymous
Guest
We are the joke of the industry. I am considered a aggressive rep but i get tired of hearing story's about how Novo does this and that, sanofi does this or that. When I sold Cymbalta how forrest did this or that.
Stop getting pushed around, win your offices. Fight fire with fire. Yes we have a corporate climate that seems to not understand how to win, and removes all our ammuniation, then wonder why we are losing market share. However, if you think through your steps before you go in a office, vs simply walking in all ditzy, and gossiping with the staff, and continue to bond, but strategically address all false things being thrown our way, do not let novo or Sanofi move your stuff around, build soldiers in the office for you. Then proactively build a ally in your top prescribers.
Sure Victoza is a one shot a day vs 2. But who can afford it, and if they cant afford it then what good is it gonna do. What mg dosage unit did Novo conduct their test at was it 1.8mg or the 1.2 that most of their patients are on. If so, then what efficacy are those patients getting. I am seeing a lot of Victoza, and they are getting switched back after one script due to cost and due to its not keeping its efficacy. Some times it is actually being more effictive than Byetta in all honesty. However, my doctors are also aware of the long term trial data that Novo has hinted at but does not market the values of it, because it shows a drop in sustained efficacy vs Byetta, and I simply ask them so is the goal short term control or long term. You have 4-5 years with byetta and for those (lets be honest there are side effect issues with some) that do not complain and are having good control keep them on byetta, for those that cant afford victoza byetta, for those that you think will be on a GLP1 for a long time why use a drug that the data only shows short term success, and we are using thier data....
Sure we are going to see growth with victoza we should. Its one shot a day vs two. Do not go int our offices looking like idiots. However stop laying down.
Stop getting pushed around, win your offices. Fight fire with fire. Yes we have a corporate climate that seems to not understand how to win, and removes all our ammuniation, then wonder why we are losing market share. However, if you think through your steps before you go in a office, vs simply walking in all ditzy, and gossiping with the staff, and continue to bond, but strategically address all false things being thrown our way, do not let novo or Sanofi move your stuff around, build soldiers in the office for you. Then proactively build a ally in your top prescribers.
Sure Victoza is a one shot a day vs 2. But who can afford it, and if they cant afford it then what good is it gonna do. What mg dosage unit did Novo conduct their test at was it 1.8mg or the 1.2 that most of their patients are on. If so, then what efficacy are those patients getting. I am seeing a lot of Victoza, and they are getting switched back after one script due to cost and due to its not keeping its efficacy. Some times it is actually being more effictive than Byetta in all honesty. However, my doctors are also aware of the long term trial data that Novo has hinted at but does not market the values of it, because it shows a drop in sustained efficacy vs Byetta, and I simply ask them so is the goal short term control or long term. You have 4-5 years with byetta and for those (lets be honest there are side effect issues with some) that do not complain and are having good control keep them on byetta, for those that cant afford victoza byetta, for those that you think will be on a GLP1 for a long time why use a drug that the data only shows short term success, and we are using thier data....
Sure we are going to see growth with victoza we should. Its one shot a day vs two. Do not go int our offices looking like idiots. However stop laying down.